Annual report pursuant to Section 13 and 15(d)

Summary of significant accounting policies (Details Narrative)

v3.10.0.1
Summary of significant accounting policies (Details Narrative) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Cash and Cash Equivalents $ 14,816,717 $ 9,631,520 $ 4,155,444
Impairment charges on assets held for sale $ 349,571 $ 0  
Vesting period 4 years    
Description of vesting period

(generally vesting either ratably over the first four years or on a tier basis of 50% on the second anniversary of the effective date and 25% on the third and fourth anniversary dates).

   
Share outstanding 734,561 1,460,632  
Patents [Member]      
Useful lives 15 years    
Minimum [Member]      
Estimated useful lives P2Y    
Maximum [Member]      
Estimated useful lives P11Y